Project Affinity: Excess Cancer Blood Testing

NCT04724005 — Completed, 613 participants, Entia Ltd
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Project Affinity: Excess Cancer Blood Testing Technique

RegistryNCT04724005
StatusCompleted
Study typeObservational
Enrollment613 (Actual)
SponsorEntia Ltd (Industry)
ConditionsCancer
InterventionsNo drug (Other)
Datesstart 2021-04-15, primary completion 2022-08-31, completion 2022-08-31, first posted 2021-01-26, last updated 2022-09-29
Locations1 site in United Kingdom

Related Papers Related Patents Related Grants Related Experts
All trials for Cancer All trials of No drug

-Summary

Study investigating cancer blood samples on an iterative measurement systme

Expand all sections  ·  Collapse all

+Arms and interventions

  • No drug (Other): No drug used

+Outcome measures

Primary outcomes

  • Viability of measurement technique [12 months]: Viability of measurement technique

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Undergoing SACT
* Routine blood tests

Exclusion Criteria:

* Not had first cycle of SACT

+Locations (1)

FacilityCityCountryStatus
The Christie NHS Foundation TrustManchesterUnited Kingdom